Welcome to LookChem.com Sign In|Join Free
  • or
Henan Tianfu Chemical Co., Ltd.Masitinib (AB1010)//file1.lookchem.com/cas/reactions/2021/07/05/12083382.png
qq

Communicate with Supplier:

Mr. Anson
Mr. Anson: What can I do for you?

Masitinib (AB1010) CAS NO.790299-79-5

Min.Order Quantity:
1 Kilogram
Purity:
99.0%
Port:
SHANGHAI
Payment Terms:
L/C,D/A,D/P,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

  • Masitinib (AB1010)
  • 790299-79-5
  • Masitinib (AB1010)

Quick Details

  • ProName: Masitinib (AB1010)
  • CasNo: 790299-79-5
  • Molecular Formula: C28H30N6OS
  • Appearance: Off-White to Pale Yellow Solid
  • Application: Organic Chemicals
  • DeliveryTime: PROMPT
  • PackAge: IN 25kg drums
  • Port: SHANGHAI
  • ProductionCapacity: 10 Metric Ton/Month
  • Purity: 99.0%
  • Storage: In Room Temperature
  • Transportation: As Per MSDS
  • LimitNum: 1 Kilogram
  • Heavy metal: N/A
  • Grade: Industrial Grade,Food Grade,Pharma Gra...
  • Transportation: N/A

Superiority

masitinib (ab1010) basic information
product name: masitinib (ab1010)
synonyms: masitinib;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide;4-((4-methylpiperazin-1-yl)methyl)-n-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide;ab 1010;ab1010;ab-1010;mastinib;masitinib(ab1010)
cas: 790299-79-5
mf: c28h30n6os
mw: 498.64
einecs:
product categories: heterocycles;intermediates & fine chemicals;pharmaceuticals;sulfur & selenium compounds;anti-cancer&immunity;inhibitors
mol file: 790299-79-5.mol
masitinib (ab1010) structure

Details

masitinib (ab1010) chemical properties
mp 90-95c
storage temp. refrigerator

masitinib (ab1010) usage and synthesis
chemical properties off-white to pale yellow solid
usage masitinib is a novel tyrosine kinases inhibitor for kit and pdgfrα/β with ic50 of 200 nm and 540 nm/800 nm, resectively.
usage masitinib is a novel inhibitor for kit and pdgfrα/β with ic50 of 200 nm and 540 nm/800 nm, weak inhibition to abl and c-fms. phase 2/3
usage masitinib controlled-release implant for treating solid neoplasm.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)